These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21189159)

  • 1. Rapid functional screening of effective siRNAs against Plk1 and its growth inhibitory effects in laryngeal carcinoma cells.
    Lan H; Zhu J; Ai Q; Yang Z; Ji Y; Hong S; Song F; Bu Y
    BMB Rep; 2010 Dec; 43(12):818-23. PubMed ID: 21189159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.
    Bu Y; Yang Z; Li Q; Song F
    Oncology; 2008; 74(3-4):198-206. PubMed ID: 18714168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.
    Reagan-Shaw S; Ahmad N
    FASEB J; 2005 Apr; 19(6):611-3. PubMed ID: 15661849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational combinations of siRNAs targeting Plk1 with breast cancer drugs.
    Spänkuch B; Kurunci-Csacsko E; Kaufmann M; Strebhardt K
    Oncogene; 2007 Aug; 26(39):5793-807. PubMed ID: 17369857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets.
    Ding Y; Huang D; Zhang Z; Smith J; Petillo D; Looyenga BD; Feenstra K; Mackeigan JP; Furge KA; Teh BT
    Cancer Res; 2011 Aug; 71(15):5225-34. PubMed ID: 21642374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.
    Xu WJ; Zhang S; Yang Y; Zhang N; Wang W; Liu SY; Tian HW; Dai L; Xie Q; Zhao X; Wei YQ; Deng HX
    Cancer Biother Radiopharm; 2011 Aug; 26(4):427-36. PubMed ID: 21797676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Plk1 induces mitotic infidelity and embryonic growth defects in developing zebrafish embryos.
    Jeong K; Jeong JY; Lee HO; Choi E; Lee H
    Dev Biol; 2010 Sep; 345(1):34-48. PubMed ID: 20553902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
    Liu X; Choy E; Harmon D; Yang S; Yang C; Mankin H; Hornicek FJ; Duan Z
    Anticancer Drugs; 2011 Jun; 22(5):444-53. PubMed ID: 21399492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
    Lee C; Fotovati A; Triscott J; Chen J; Venugopal C; Singhal A; Dunham C; Kerr JM; Verreault M; Yip S; Wakimoto H; Jones C; Jayanthan A; Narendran A; Singh SK; Dunn SE
    Stem Cells; 2012 Jun; 30(6):1064-75. PubMed ID: 22415968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polo-like kinase 1 contributes to the tumorigenicity of BEL-7402 hepatoma cells via regulation of Survivin expression.
    He Z; Wu J; Dang H; Lin H; Zheng H; Zhong D
    Cancer Lett; 2011 Apr; 303(2):92-8. PubMed ID: 21330050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small interfering RNA-mediated Polo-like kinase 1 depletion preferentially reduces the survival of p53-defective, oncogenic transformed cells and inhibits tumor growth in animals.
    Guan R; Tapang P; Leverson JD; Albert D; Giranda VL; Luo Y
    Cancer Res; 2005 Apr; 65(7):2698-704. PubMed ID: 15805268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of growth inhibition of gastric cancer cells by sRNA targeting polo like kinase 1 in vitro and vivo].
    Lan B; Liu BY; Cheng XH; Qu Y; Zhang XQ; Cai Q; Dai QB; Zhu ZG
    Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(1):40-4. PubMed ID: 16620646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plk1 is negatively regulated by RNF8.
    Yoshioka T; Kimura M; Saio M; Era S; Okano Y
    Biochem Biophys Res Commun; 2011 Jun; 410(1):57-61. PubMed ID: 21635870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting XIAP expression by RNAi to inhibit proliferation and enhance radiosensitivity in laryngeal cancer cell line.
    Wang R; Li B; Wang X; Lin F; Gao P; Cheng SY; Zhang HZ
    Auris Nasus Larynx; 2009 Jun; 36(3):332-9. PubMed ID: 19013033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro.
    Kawata E; Ashihara E; Nakagawa Y; Kiuchi T; Ogura M; Yao H; Sakai K; Tanaka R; Nagao R; Yokota A; Takeuchi M; Kimura S; Hirai H; Maekawa T
    Cancer Lett; 2010 Aug; 294(2):245-53. PubMed ID: 20206440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel treatment strategy targeting polo-like kinase 1 in hematological malignancies.
    Ikezoe T; Yang J; Nishioka C; Takezaki Y; Tasaka T; Togitani K; Koeffler HP; Yokoyama A
    Leukemia; 2009 Sep; 23(9):1564-76. PubMed ID: 19421227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of PLK1 gene silence on apoptosis of K562 cells].
    Zhang M; Chen ZC; Liu F; You Y; Liu ZP; Zou P
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):715-8. PubMed ID: 16620572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Polo-like kinase in cancer therapy.
    Degenhardt Y; Lampkin T
    Clin Cancer Res; 2010 Jan; 16(2):384-9. PubMed ID: 20068088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polo-like kinase inhibitor BI 2536 exhibits potent activity against malignant plasma cells and represents a novel therapy in multiple myeloma.
    Stewart HJ; Kishikova L; Powell FL; Wheatley SP; Chevassut TJ
    Exp Hematol; 2011 Mar; 39(3):330-8. PubMed ID: 21184800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor inhibition by genomically integrated inducible RNAi-cassettes.
    Kappel S; Matthess Y; Zimmer B; Kaufmann M; Strebhardt K
    Nucleic Acids Res; 2006; 34(16):4527-36. PubMed ID: 16945954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.